30 results were returned
In the LexisNexis case analysis, Senior IP Associate, Will Smith, talks about the decision in the following matter: Neurim Pharmaceuticals (1991) Ltd & Anor v Generics UK Ltd (t\a MYLAN)  EWHC 3270 (Pat). This ...
The Supreme Court has held that two patents for a transgenic mouse used for the development of human antibodies were invalid for insufficiency.
This decision follows the recent trend for the ECJ to give more straightforward interpretations of the SPC Regulation, providing certainty for users of the system.
The specialised Section No. 15 of the Appeal Court of Barcelona has recently clarified what indirect infringement means by its judgment of 13 November 2020 (rapporteur Justice Rodríguez Vega, No. 2410/2020, Ortho.pras ...
By resolution dated February 10, 2021 the Italian Medicines Agency (AIFA) clarified the criteria for generic medicinal products to be inserted in the Substitution List (“Lista di Trasparenza”).
Will Smith discusses the unusual decision of a judge to vary his order made after trial where a patent upheld by him was revoked by the European Patent Office almost immediately after the order was made
Our international IP team are thrilled to announce the promotion of 3 new partners today. These promotions reflect our ongoing commitment to ensure the diversity of our team develops to reflect the rich pool of talent ...
Diverging from the previous decision, the Court pointed out that the relevance of the file history to construe the scope of protection of a patent and then the infringement of equivalence has to be carefully and ...
We are delighted to announce that we received four prestigious awards at the Who’s Who Legal Awards 2020 held virtually in November.
Our Australian competition and IP team have recently contributed a chapter to the Fifth Edition of The Intellectual Property and Antitrust Review.